• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Psychedelics Market
    Psychedelics News
    Psychedelics Stocks
    • Psychedelics Market
    • Psychedelics News
    • Psychedelics Stocks
    psychedelics investing

    Awakn Life Sciences to Present at the KCSA Psychedelics Virtual Investor Conference on October 13th

    Written by Investing News Network
    |
    Oct. 08, 2021 06:30AM PST
    agriculture and life sciences
    Awakn Life Sciences Corp. a biotechnology company developing and delivering psychedelic therapeutics to treat Addiction, announced today that Anthony Tennyson, CEO of Awakn Life Sciences, will participate in the KCSA Psychedelics Investor Conference to be held at VirtualInvestorConferences.com on October 13-14, 2021.Anthony Tennyson will present live on Wednesday, October 13th at 10:30 a.m. ET. Register to attend ...

    Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company developing and delivering psychedelic therapeutics (medicines and therapies) to treat Addiction, announced today that Anthony Tennyson, CEO of Awakn Life Sciences, will participate in the KCSA Psychedelics Investor Conference to be held at VirtualInvestorConferences.com on October 13-14, 2021.

    Anthony Tennyson will present live on Wednesday, October 13th at 10:30 a.m. ET. Register to attend here.

    For more information about the conference, or to schedule a one-on-one meeting with Awakn's management team, please contact KCSA Strategic Communications at Awakn@kcsa.com.

    Awakn also announces it has retained the services of JRZ Capital LLC ("JRZ"), an investor communications and public relations company, to assist the Company to enhance its market awareness, and communications strategy. JRZ has agreed to comply with all applicable securities laws and the policies of all applicable stock exchanges in providing services to the Company. Under the terms of the JRZ engagement, which is for an initial two-month period, JRZ will be paid US$150,000 per month.

    About Awakn Life Sciences Corp.

    Awakn Life Sciences is a biotechnology company with clinical operations, developing and delivering psychedelic therapeutics (medicines and therapies) to better treat addiction. Awakn's team consists of world leading chemists, scientists, psychiatrists, and psychologists who are developing and advancing the next generation of psychedelic drugs, therapies, and enabling technologies to treat addiction. Awakn will deliver these evidence backed psychedelic therapies in clinics in the UK and Europe and through licensing partnerships globally.

    www.awaknlifesciences.com | Twitter | LinkedIn | Facebook

    Investor Enquiries:
    KCSA Strategic Communications
    Valter Pinto / Tim Regan
    Phone: +1 (212) 896-1254
    Awakn@KCSA.com

    Media Enquiries:
    America and Canada: KCSA Strategic Communications
    Anne Donohoe
    Adonohoe@KCSA.com

    Rest of World: ROAD Communications
    Paul Jarman / Anna Ramsey
    Awakn@roadcommunications.co.uk

    Corporate Logo

    To view the source version of this press release, please visit https://www.newsfilecorp.com/release/99032

    News Provided by Newsfile via QuoteMedia

    psychedelics investingneo:awkn
    The Conversation (0)

    Go Deeper

    AI Powered
    Psychedelics Outlook Report

    Psychedelics Outlook Report

    A colorful brain illustrating brain on pyschedelics.

    Psychedelics Stocks to Watch

    Latest News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Stocks

    Melodiol Global Health

    Melodiol Global Health (ME1:AU)
    ME1:AU

    Albert Labs

    Albert Labs (ABRT:CC)
    ABRT:CC

    Optimi Health

    Optimi Health (OPTI:CC)
    OPTI:CC

    Nirvana Life Sciences

    Nirvana Life Sciences (NIRV:CC)
    NIRV:CC

    Love Pharma

    Love Pharma (LUV:CC)
    LUV:CC
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES